CSIR, Aurobindo Pharma collaborate to develop COVID-19 vaccine

Under the signed agreement between CSIR-Centre for Cellular and Molecular Biology (CCMB) here and Aurobindo Pharma, Aurobindo will partner with CSIR for development of several novel COVID-19 vaccines, the CCMB said in a release on Tuesday.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...